Metominostrobin

Metominostrobin

SCHEMBL912965

CNC(=O)/C(=N\OC)c1ccccc1Oc1ccccc1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.49
CTNNB1 P35222 2/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 4/20 0.43
TSHR P16473 3/20 0.43
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
TCF4 P15884 1/20 0.41
TCF7L2 Q9NQB0 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPK1 P28482 2/20 0.40
MAPK8 P45983 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metominostrobin SCHEMBL29736874 1.00 RAB9A (0.49) RAB9ACTNNB1MEN1KMT2AL3MBTL1
Metominostrobin SCHEMBL54680 1.00 RAB9A (0.49) RAB9ACTNNB1MEN1KMT2AL3MBTL1
Metominostrobin SCHEMBL18652 1.00 RAB9A (0.49) RAB9ACTNNB1MEN1KMT2AL3MBTL1
Metominostrobin SCHEMBL29376726 1.00 RAB9A (0.49) RAB9ACTNNB1MEN1KMT2AL3MBTL1
Metominostrobin SCHEMBL28036690 0.99 RAB9A (0.48) RAB9ACTNNB1MEN1KMT2AL3MBTL1
SCHEMBL8954809 0.97 MEN1 (0.49) RAB9ACTNNB1MEN1KMT2AL3MBTL1
SCHEMBL8369618 0.97 MEN1 (0.49) RAB9ACTNNB1MEN1KMT2AL3MBTL1
SCHEMBL8369620 0.97 MEN1 (0.49) RAB9ACTNNB1MEN1KMT2AL3MBTL1
SCHEMBL8954792 0.94 RAB9A (0.44) RAB9ACTNNB1MEN1KMT2AL3MBTL1
SCHEMBL8370504 0.94 RAB9A (0.44) RAB9ACTNNB1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 604 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3010893-B1 ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES BAYER CROPSCIENCE AG (DE) 2019-10-02 EP claimed
EP-3010889-B1 ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES BAYER CROPSCIENCE AG (DE) 2018-10-03 EP claimed
US-20170325452-A1 Active compound combinations BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-11-16 US claimed
EP-3232783-A1 ACTIVE COMPOUND COMBINATIONS Bayer CropScience Aktiengesellschaft (DE) 2017-10-25 EP claimed
CN-107257625-A Active agent combinations 拜耳作物科学股份公司 2017-10-17 CN claimed
US-9642363-B2 N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides BAYER CROPSCIENCE AG (DE) 2017-05-09 US claimed
WO-2016096944-A1 ACTIVE COMPOUND COMBINATIONS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-06-23 WO claimed
EP-2997825-A1 ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND Bayer Intellectual Property GmbH (DE) 2016-03-23 EP claimed
US-20150313223-A1 TERNARY FUNGICIDAL MIXTURES BAYER CROPSCIENCE AG (DE) 2015-11-05 US claimed
CN-104981162-A Ternary fungicidal mixtures BAYER CROPSCIENCE AG 2015-10-14 CN claimed
CN-104754940-A Active compound combinations BAYER CROPSCIENCE AG 2015-07-01 CN claimed
WO-2014082950-A1 TERNARY FUNGICIDAL MIXTURES BAYER CROPSCIENCE AG (DE) 2014-06-05 WO claimed
WO-2014037314-A2 ACTIVE COMPOUND COMBINATIONS BAYER CROPSCIENCE AG (DE) 2014-03-13 WO claimed
WO-2014037315-A2 ACTIVE COMPOUND COMBINATIONS BAYER CROPSCIENCE AG (DE) 2014-03-13 WO claimed
CN-103635089-A Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound BAYER IP GMBH 2014-03-12 CN claimed
EP-2699093-A1 ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND Bayer Intellectual Property GmbH (DE) 2014-02-26 EP claimed
US-20140038823-A1 ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGIDICAL COMPOUND BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2014-02-06 US claimed
EP-2515649-A2 ACTIVE COMPOUND COMBINATIONS Bayer Intellectual Property GmbH (DE) 2012-10-31 EP claimed
WO-2012143127-A1 ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGICIDAL COMPOUND BAYER CROPSCIENCES AG (DE) 2012-10-26 WO claimed
EP-2011396-A1 Active compound combinations Bayer CropScience AG (DE) 2009-01-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170325452-A1 Active compound combinations NNMT, NNT, NQO2 RAB9A 2935/4885CTNNB1 4077/4885MEN1 1556/4885
US-20140038823-A1 ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGIDICAL COMPOUND AADAC, TUBA3C, NAT1 RAB9A 3615/4885CTNNB1 3978/4885MEN1 3136/4885
US-20150313223-A1 TERNARY FUNGICIDAL MIXTURES CYP4X1, ERG28, CBR3 RAB9A 3789/4885CTNNB1 4263/4885MEN1 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.